Matthew Scott Harris - Chief Medical Officer at Altimmune, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Matthew Scott Harris since 14 Oct 2025

Reported holdings for Matthew Scott Harris in Altimmune, Inc.

Form 4 holding Chief Medical Officer

Altimmune, Inc.

Security class
Stock Options (option to buy)
Shares / value
183,600
Estimated value
Report date
27 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.0001
Underlying amount
Form 4 holding Chief Medical Officer

Altimmune, Inc.

Security class
Restricted Stock Units
Shares / value
7,775
Estimated value
Report date
02 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock, par value $0.0001
Underlying amount

Transaction history for Matthew Scott Harris in Altimmune, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .